le dimanche 22 juillet 2018, à 02:32. Posté
par Theron
Please wait http://www.ind-ong.org/pharmacyjdcom-e898.pdf#departments kestonmedical.nhs.uk Vertex said the U.S. Food and Drug Administration took theaction after the Phase II study in Europe of its VX-135 incombination with the standard hepatitis drug ribavirin showedelevated liver enzymes in three patients taking the 400milligram dose of its drug.